Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study.

Edouard L Fu Elvira D'Andrea Deborah J WexlerElisabetta PatornoJulie M Paik

Published in: Clinical journal of the American Society of Nephrology : CJASN (2023)

In US patients with CKD and type 2 diabetes receiving routine care, SGLT2i use was associated with higher risks of genital infections and potentially lower limb amputations and nonvertebral fractures.

Keyphrases

type diabetes
lower limb
chronic kidney disease
glycemic control

healthcare
cardiovascular disease
palliative care

human health
metabolic syndrome
adipose tissue

affordable care act
skeletal muscle
health insurance